Rose Eli Grassi Rici

Dr. Rose Eli Grassi Rici


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2025 in Biology
Verified
Journal Article
Open access
PDF file
.A.Felipe R. Azarias
.Felipe R. Azarias
GAGustavo Henrique Doná Rodrigues Almeida
Gustavo Henrique Doná Rodrigues Almeida
LMLuana Félix de Melo
Luana Félix de Melo
RRRose Eli Grassi Rici
Rose Eli Grassi Rici
DMDurvanei Maria
Durvanei Maria
The Default Mode Network has been extensively studied in recent decades due to its central role in higher cognitive processes and its relevance for understanding mental disorders. This neural network, characterized by synchronized and coherent activity at rest, is intrinsically linked to self-reflection, mental exploration, social interaction, and emotional processing. Our understanding of the DMN extends beyond humans to non-human animals, where it has been observed in various species, highlighting its evolutionary basis and adaptive significance throughout phylogenetic history. Additionally, the DMN plays a crucial role in brain development during childhood and adolescence, influencing fundamental cognitive and emotional processes. This literature review aims to provide a comprehensive overview of the DMN, addressing its structural, functional, and evolutionary aspects, as well as its impact from infancy to adulthood. By gaining a deeper understanding of the organization and function of the DMN, we can advance our knowledge of the neural mechanisms that underlie cognition, behavior, and mental health. This, in turn, can lead to more effective therapeutic strategies for a range of neuropsychiatric conditions.

22 February 2012 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
RRRose Eli Grassi Rici
Rose Eli Grassi Rici
DADayane Alcântara
Dayane Alcântara
PFPaula Fratini
Paula Fratini
CWCristiane Valverde Wenceslau
Cristiane Valverde Wenceslau
CACarlos Eduardo Ambrosio
Carlos Eduardo Ambrosio
DMDurvanei Maria
Durvanei Maria
Background: The bone morphogenetic proteins (BMPs) belong to a unique group of proteins that includes the growth factor TGF-β. BMPs play important roles in cell differentiation, cell proliferation, and inhibition of cell growth. They also participate in the maturation of several cell types, depending on the microenvironment and interactions with other regulatory factors. Depending on their concentration gradient, the BMPs can attract various types of cells and act as chemotactic, mitogenic, or differentiation agents. BMPs can interfere with cell proliferation and the formation of cartilage and bone. In addition, BMPs can induce the differentiation of mesenchymal progenitor cells into various cell types, including chondroblasts and osteoblasts. The aim of this study was to analyze the effects of treatment with rhBMP-2 on the proliferation of canine mesenchymal stem cells (cMSCs) and the tumor suppression properties of rhBMP-2 in canine osteocarcoma (OST) cells. Osteosarcoma cell lines were isolated from biopsies and excisions of animals with osteosarcoma and were characterized by the Laboratory of Biochemistry and Biophysics, Butantan Institute. The mesenchymal stem cells were derived from the bone marrow of canine fetuses (cMSCs) and belong to the University of São Paulo, College of Veterinary Medicine (FMVZ-USP) stem cell bank. After expansion, the cells were cultured in a 12-well Transwell system; cells were treated with bone marrow mesenchymal stem cells associated with rhBMP2. Expression of the intracytoplasmic and nuclear markers such as Caspase-3, Bax, Bad, Bcl-2, Ki-67, p53, Oct3/4, Nanog, Stro-1 were performed by flow citometry.Results: We evaluated the regenerative potential ofin vitrotreatment with rhBMP-2 and found that both osteogenic induction and tumor regression occur in stem cells from canine bone marrow. rhBMP-2 inhibits the proliferation capacity of OST cells by mechanisms of apoptosis and tumor suppression mediated by p53.Conclusion: We propose that rhBMP-2 has great therapeutic potential in bone marrow cells by serving as a tumor suppressor to increase p53 and the pro-apoptotic proteins Bad and Bax, as well as by increasing the activity of phosphorylated caspase 3.Study design: Canine bone marrow mesenchymal stem cells associated with rhBMP2 in canine osteosarcoma treatment: "in vitro" study

8 April 2022 in Viruses
Verified
Journal Article
Open access
PDF file
RUY DIEGO CHACON VILLANUEVARUY DIEGO CHACON VILLANUEVA
RUY DIEGO CHACON VILLANUEVA
CFClaudete Serrano Astolfi Ferreira
Claudete Serrano Astolfi Ferreira
PPPatrícia C. Pereira
Patrícia C. Pereira
MAMario S. Assayag
Mario S. Assayag
ACAntony B. Campos-Salazar
Antony B. Campos-Salazar
AFAntonio J. Piantino Ferreira
Antonio J. Piantino Ferreira
Avipoxvirus affects chickens and wild birds, and it is characterized by lesions on the nonfeathered parts of the body (the cutaneous form), or necrotic lesions in the upper respiratory tract (the diphtheritic form). In poultry farming, avian pox is usually controlled by live attenuated vaccines. However, there have been many reports of outbreaks, even in flocks of vaccinated birds. In the present study, different outbreaks of the emerging clade E avipoxvirus were detected in commercial breeder flocks of chickens vaccinated against fowlpox virus in Southeast Brazil. Clinical manifestations of these outbreaks included a marked prevalence of moderate to severe progressive lesions in the beaks of affected birds, especially in roosters with increased mortality (up to 8.48%). Also, a reduced hatchability (up to 20.77% fewer hatching eggs) was observed in these flocks. Analysis of clinical samples through light and transmission electron microscopy revealed the presence of Bollinger bodies and poxvirus particles in epithelial cells and affecting chondrocytes. PCR, sequencing, and phylogenetic analysis of major core protein (P4b) and DNA polymerase (pol) genes identified this virus as clade E avipoxvirus. We also developed qPCR assays for open reading frames (ORFs) 49, 114, and 159 to detect and quantify this emergent virus. These results show the arrival and initial spread of this pathogen in the poultry industry, which was associated with harmful outbreaks and exacerbated clinical manifestations in vaccinated commercial breeder flocks. This study also highlights the relevance of permanent vigilance and the need to improve sanitary and vaccination programs.

10 February 2016 in Zoomorphology
Verified
Journal Article
Closed access
PDF file
BRBianca S. Rangel
Bianca S. Rangel
Adriano Polican CienaAdriano Polican Ciena
Adriano Polican Ciena
NWNatascha Wosnick
Natascha Wosnick
AAAlberto Ferreira de Amorim
Alberto Ferreira de Amorim
JJJose Roberto Kfoury Junior
Jose Roberto Kfoury Junior
RRRose Eli Grassi Rici
Rose Eli Grassi Rici

7 November 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Sandra Maria BarbalhoSandra Maria Barbalho
Sandra Maria Barbalho
KPKarina Torres Pomini
Karina Torres Pomini
ELEnzo Pereira de Lima
Enzo Pereira de Lima
JOJéssica da Silva Camarinha Oliveira
Jéssica da Silva Camarinha Oliveira
BBBeatriz Boaro
Beatriz Boaro
Lucas Fornari LaurindoLucas Fornari Laurindo
Lucas Fornari Laurindo
Cinobufagin (CB), a bufadienolide, has shown promising potential as an anticancer agent, particularly in combating lung cancer. This systematic review synthesizes preclinical evidence on CB’s effects against lung cancer, focusing on its mechanisms of action, efficacy, and potential clinical implications. We analyzed data from various preclinical studies involving both in vitro cell line models and in vivo animal models. The reviewed studies indicate that CB effectively reduces cell viability, induces apoptosis, and inhibits cell proliferation, migration, and invasion across multiple lung cancer cell lines and xenograft models. Specifically, CB was found to decrease cell viability and increase apoptosis in lung cancer cells by modulating key molecular pathways, including Bcl-2, Bax, cleaved caspases, caveolin-1, FLOT2, Akt, STAT3, and FOXO1. In vivo studies further demonstrated significant inhibition of tumor growth with minimal toxicity. However, limitations include reliance on in vitro models, which may not fully represent in vivo tumor dynamics, and a lack of long-term safety data. The studies also vary in their methodologies and cell line models, which may not accurately encompass all lung cancer subtypes or predict human responses. Despite these limitations, CB’s ability to target specific molecular pathways and its promising results in preclinical models suggest it could be a valuable addition to lung cancer treatment strategies. Our review suggests further clinical trials to validate its efficacy and safety in humans. Future research should explore combination therapies and optimize delivery methods to enhance clinical outcomes.

20 May 2018 in Veterinary and Comparative Oncology
Verified
Journal Article
Closed access
PDF file
RRRose Eli Grassi Rici
Rose Eli Grassi Rici
SWS. E. A. L. Will
S. E. A. L. Will
ALA. C. L. Luna
A. C. L. Luna
LML. F. Melo
L. F. Melo
ASA. C. Santos
A. C. Santos
DMD. A. Maria
D. A. Maria